Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery

Abstract

Bevacizumab is effective and safe for the treatment of RN after SRS for brain metastasis. In this context, bevacizumab offers symptomatic relief, a reduction in steroid requirement, and a dramatic radiographic response.